Surv BioPharma
Developer of gene therapies designed to improve the treatment of various diseases. The company's platform utilizes drug delivery systems and targeted therapy approaches, aiming to enhance drug efficac...
Valuation
$28.8M
Latest known
Share Price
N/A
Total Raised
$17.2M
Last Round
N/A